Picture of Kezar Life Sciences logo

KZR — Kezar Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Kezar Life Sciences Says Preliminarily Estimates That Cash, Equivalents And Marketable Securities As Of June 30, 2022 Were Approximately $307 Million

July 11 (Reuters) - Kezar Life Sciences Inc  KZR.O :
    * KEZAR LIFE SCIENCES - PRELIMINARILY ESTIMATES THAT ITS
CASH,
EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2022 WERE
APPROXIMATELY $307 MILLION

Further company coverage:  KZR.O

Recent news on Kezar Life Sciences

See all news